Advancing EHS and Procurement: Ipsen’s Path to a Sustainable 2030 - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Statements
    • Media Library
    • Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
    • Profiles
    • Pipeline
    • Partnering
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories

Post navigation

Previous
Next

Advancing EHS and Procurement: Ipsen’s Path to a Sustainable 2030

Advancing EHS and Procurement: Ipsen’s Path to a Sustainable 2030

- 29 July 2025 - 0 mins read

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook
Related Documents
  • Advancing EHS and Procurement: Ipsen’s Path to a Sustainable 2030   Download  (179 KB)

Related ESG Documents

ISO 45001 : 2018 – Ipsen
05 September 2025 0 mins read

ISO 45001 : 2018 – Ipsen
ISO 14001 : 2015 – Ipsen
05 September 2025 0 mins read

ISO 14001 : 2015 – Ipsen
Ipsen’s Risk Appetite
01 August 2025 0 mins read

Ipsen’s Risk Appetite
Ipsen Public Policy Activities Statement 2025
28 July 2025 0 mins read

Ipsen Public Policy Activities Statement 2025
2024 HR KPIs – A glimpse on our workplace and workforce
17 July 2025 0 mins read

2024 HR KPIs – A glimpse on our workplace and workforce
Ipsen Sustainable Procurement Ambition
24 September 2024 0 mins read

Ipsen Sustainable Procurement Ambition
Group EHS Policy Commitment
16 September 2024 0 mins read

Group EHS Policy Commitment
Modern Slavery Statement
04 September 2024 0 mins read

Modern Slavery Statement
Ipsen Public Policy Activities
12 July 2024 0 mins read

Ipsen Public Policy Activities
2023 HR KPIs – A glimpse on our workplace and workforce
12 July 2024 0 mins read

2023 HR KPIs – A glimpse on our workplace and workforce

IPN price

€118.90

 €0.00 (0.00%)

  • Media Library
  • Annual Report
  • Contacts
  • Our Locations
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue